ReP USP - Resultado da busca

Artigo de periodico
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study (2023)
Doskaliuk, Bohdana; Ravichandran, Naveen ; Sen, Parikshit ; Day, Jessica ; Joshi, Mrudula; Nune, Arvind; Nikiphorou, Elena ; Saha, Sreoshy ; Tan, Ai Lyn; Shinjo, Samuel Katsuyuki
Source: Rheumatology international. Unidade: FM
Subjects: VACINAÇÃO, COVID-19, MIOSITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOSKALIUK, Bohdana et al. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology international, v. 43, n. 9, p. 1651-1664, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/55968. Acesso em: 13 set. 2024.
APA
Doskaliuk, B., Ravichandran, N., Sen, P., Day, J., Joshi, M., Nune, A., et al. (2023). Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology international, 43( 9), 1651-1664. doi:10.1007/s00296-023-05345-y
NLM
Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study [Internet]. Rheumatology international. 2023 ; 43( 9): 1651-1664.[citado 2024 set. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55968
Vancouver
Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study [Internet]. Rheumatology international. 2023 ; 43( 9): 1651-1664.[citado 2024 set. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55968
Artigo de periodico
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey (2023)
Grignaschi, Silvia; Kim, Minchul; Zanframundo, Giovanni; Ravichandran, Naveen ; Lilleker, James B. ; Sen, Parikshit ; Joshi, Mrudula; Agarwal, Vishwesh ; Kardes, Sinan ; Day, Jessica ; Shinjo, Samuel Katsuyuki
Source: Rheumatology international. Unidade: FM
Subjects: DOENÇAS AUTOIMUNES, QUESTIONÁRIOS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRIGNASCHI, Silvia et al. High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey. Rheumatology international, v. 43, n. 9, p. 1637-1649, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/55990. Acesso em: 13 set. 2024.
APA
Grignaschi, S., Kim, M., Zanframundo, G., Ravichandran, N., Lilleker, J. B., Sen, P., et al. (2023). High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey. Rheumatology international, 43( 9), 1637-1649. doi:10.1007/s00296-023-05344-z
NLM
Grignaschi S, Kim M, Zanframundo G, Ravichandran N, Lilleker JB, Sen P, Joshi M, Agarwal V, Kardes S, Day J, Shinjo SK. High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey [Internet]. Rheumatology international. 2023 ; 43( 9): 1637-1649.[citado 2024 set. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55990
Vancouver
Grignaschi S, Kim M, Zanframundo G, Ravichandran N, Lilleker JB, Sen P, Joshi M, Agarwal V, Kardes S, Day J, Shinjo SK. High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey [Internet]. Rheumatology international. 2023 ; 43( 9): 1637-1649.[citado 2024 set. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55990
Artigo de periodico
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol (2022)
Sen, Parikshit; Gupta, Latika; Lilleker, James B; Aggarwal, Vishwesh; Kardes, Sinan; Milchert, Marcin; Gheita, Tamer; Salim, Babur; Velikova, Tsvetelina; Shinjo, Sueli Mieko Oba
Source: Rheumatology international. Unidade: FM
Subjects: COVID-19, PANDEMIAS, DOENÇAS AUTOIMUNES, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEN, Parikshit et al. COVID-19 vaccination in autoimmune disease (COVAD) survey protocol. Rheumatology international, v. 42, n. 1, p. 23-29, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00296-021-05046-4. Acesso em: 13 set. 2024.
APA
Sen, P., Gupta, L., Lilleker, J. B., Aggarwal, V., Kardes, S., Milchert, M., et al. (2022). COVID-19 vaccination in autoimmune disease (COVAD) survey protocol. Rheumatology international, 42( 1), 23-29. doi:10.1007/s00296-021-05046-4
NLM
Sen P, Gupta L, Lilleker JB, Aggarwal V, Kardes S, Milchert M, Gheita T, Salim B, Velikova T, Shinjo SMO. COVID-19 vaccination in autoimmune disease (COVAD) survey protocol [Internet]. Rheumatology international. 2022 ; 42( 1): 23-29.[citado 2024 set. 13 ] Available from: https://doi.org/10.1007/s00296-021-05046-4
Vancouver
Sen P, Gupta L, Lilleker JB, Aggarwal V, Kardes S, Milchert M, Gheita T, Salim B, Velikova T, Shinjo SMO. COVID-19 vaccination in autoimmune disease (COVAD) survey protocol [Internet]. Rheumatology international. 2022 ; 42( 1): 23-29.[citado 2024 set. 13 ] Available from: https://doi.org/10.1007/s00296-021-05046-4
Artigo de periodico
COVAD survey 2 long-term outcomes: unmet need and protocol (2022)
Fazal, Zoha Zahid; Sen, Parikshit; Joshi, Mrudula; Ravichandran, Naveen; Lilleker, James B; Agarwal, Vishwesh; Kardes, Sinan; Kim, Minchul; Day, Jessica; Shinjo, Samuel Katsuyuki
Source: Rheumatology international. Unidade: FM
Subjects: DOENÇAS AUTOIMUNES, COVID-19, VACINAÇÃO, PANDEMIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAZAL, Zoha Zahid et al. COVAD survey 2 long-term outcomes: unmet need and protocol. Rheumatology international, v. 42, n. 12, p. 2151-2158, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00296-022-05157-6. Acesso em: 13 set. 2024.
APA
Fazal, Z. Z., Sen, P., Joshi, M., Ravichandran, N., Lilleker, J. B., Agarwal, V., et al. (2022). COVAD survey 2 long-term outcomes: unmet need and protocol. Rheumatology international, 42( 12), 2151-2158. doi:10.1007/s00296-022-05157-6
NLM
Fazal ZZ, Sen P, Joshi M, Ravichandran N, Lilleker JB, Agarwal V, Kardes S, Kim M, Day J, Shinjo SK. COVAD survey 2 long-term outcomes: unmet need and protocol [Internet]. Rheumatology international. 2022 ; 42( 12): 2151-2158.[citado 2024 set. 13 ] Available from: https://doi.org/10.1007/s00296-022-05157-6
Vancouver
Fazal ZZ, Sen P, Joshi M, Ravichandran N, Lilleker JB, Agarwal V, Kardes S, Kim M, Day J, Shinjo SK. COVAD survey 2 long-term outcomes: unmet need and protocol [Internet]. Rheumatology international. 2022 ; 42( 12): 2151-2158.[citado 2024 set. 13 ] Available from: https://doi.org/10.1007/s00296-022-05157-6
Artigo de periodico
Intravenous human immunoglobulin and/or methylprednisolone pulse therapies as a possible treat-to-target strategy in immune-mediated necrotizing myopathies (2019)
Souza, Jean Marcos de; Hoff, Leonardo Santos; Shinjo, Samuel Katsuyuki
Source: Rheumatology international. Unidade: FM
Subjects: IMUNOGLOBULINAS INTRAVENOSAS, DOENÇAS MUSCULARES, HORMÔNIOS GLICOCORTICOIDES, IMUNOTERAPIA, RESSONÂNCIA MAGNÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Jean Marcos de e HOFF, Leonardo Santos e SHINJO, Samuel Katsuyuki. Intravenous human immunoglobulin and/or methylprednisolone pulse therapies as a possible treat-to-target strategy in immune-mediated necrotizing myopathies. Rheumatology international, v. 39, n. 7, p. 1201-1212, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00296-019-04254-3. Acesso em: 13 set. 2024.
APA
Souza, J. M. de, Hoff, L. S., & Shinjo, S. K. (2019). Intravenous human immunoglobulin and/or methylprednisolone pulse therapies as a possible treat-to-target strategy in immune-mediated necrotizing myopathies. Rheumatology international, 39( 7), 1201-1212. doi:10.1007/s00296-019-04254-3
NLM
Souza JM de, Hoff LS, Shinjo SK. Intravenous human immunoglobulin and/or methylprednisolone pulse therapies as a possible treat-to-target strategy in immune-mediated necrotizing myopathies [Internet]. Rheumatology international. 2019 ; 39( 7): 1201-1212.[citado 2024 set. 13 ] Available from: https://doi.org/10.1007/s00296-019-04254-3
Vancouver
Souza JM de, Hoff LS, Shinjo SK. Intravenous human immunoglobulin and/or methylprednisolone pulse therapies as a possible treat-to-target strategy in immune-mediated necrotizing myopathies [Internet]. Rheumatology international. 2019 ; 39( 7): 1201-1212.[citado 2024 set. 13 ] Available from: https://doi.org/10.1007/s00296-019-04254-3
Artigo de periodico
Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies (2019)
Borges, Isabela Bruna Pires; Shinjo, Samuel Katsuyuki
Source: Rheumatology international. Unidade: FM
Subjects: ESTATINAS, DISLIPIDEMIAS, MIOSITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Isabela Bruna Pires e SHINJO, Samuel Katsuyuki. Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies. Rheumatology international, v. 39, n. 2, p. 311-316, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00296-018-4215-x. Acesso em: 13 set. 2024.
APA
Borges, I. B. P., & Shinjo, S. K. (2019). Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies. Rheumatology international, 39( 2), 311-316. doi:10.1007/s00296-018-4215-x
NLM
Borges IBP, Shinjo SK. Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies [Internet]. Rheumatology international. 2019 ; 39( 2): 311-316.[citado 2024 set. 13 ] Available from: https://doi.org/10.1007/s00296-018-4215-x
Vancouver
Borges IBP, Shinjo SK. Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies [Internet]. Rheumatology international. 2019 ; 39( 2): 311-316.[citado 2024 set. 13 ] Available from: https://doi.org/10.1007/s00296-018-4215-x
Artigo de periodico
Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review (2018)
Borges, Isabela Bruna Pires; Silva, Marilda Guimares; Misse, Rafael Giovane; Shinjo, Samuel Katsuyuki
Source: Rheumatology international. Unidade: FM
Subjects: ESTUDOS RETROSPECTIVOS, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Isabela Bruna Pires et al. Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review. Rheumatology international, v. 38, n. 2, p. 293-301, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00296-017-3821-3. Acesso em: 13 set. 2024.
APA
Borges, I. B. P., Silva, M. G., Misse, R. G., & Shinjo, S. K. (2018). Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review. Rheumatology international, 38( 2), 293-301. doi:10.1007/s00296-017-3821-3
NLM
Borges IBP, Silva MG, Misse RG, Shinjo SK. Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review [Internet]. Rheumatology international. 2018 ; 38( 2): 293-301.[citado 2024 set. 13 ] Available from: https://doi.org/10.1007/s00296-017-3821-3
Vancouver
Borges IBP, Silva MG, Misse RG, Shinjo SK. Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review [Internet]. Rheumatology international. 2018 ; 38( 2): 293-301.[citado 2024 set. 13 ] Available from: https://doi.org/10.1007/s00296-017-3821-3
Artigo de periodico
Vascular surgery: the main risk factor for mortality in 146 Takayasu arteritis patients (2017)
Rosa Neto, Nilton Salles; Shinjo, Samuel Katsuyuki; Levy-Neto, Maurício; Pereira, Rosa maria Rodrigues
Source: Rheumatology international. Unidade: FM
Subjects: PROCEDIMENTOS CIRÚRGICOS VASCULARES, MORTALIDADE, VASCULITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSA NETO, Nilton Salles et al. Vascular surgery: the main risk factor for mortality in 146 Takayasu arteritis patients. Rheumatology international, v. 37, n. 7, p. 1065-1073, 2017Tradução . . Disponível em: https://doi.org/10.1007/s00296-017-3656-y. Acesso em: 13 set. 2024.
APA
Rosa Neto, N. S., Shinjo, S. K., Levy-Neto, M., & Pereira, R. maria R. (2017). Vascular surgery: the main risk factor for mortality in 146 Takayasu arteritis patients. Rheumatology international, 37( 7), 1065-1073. doi:10.1007/s00296-017-3656-y
NLM
Rosa Neto NS, Shinjo SK, Levy-Neto M, Pereira R maria R. Vascular surgery: the main risk factor for mortality in 146 Takayasu arteritis patients [Internet]. Rheumatology international. 2017 ; 37( 7): 1065-1073.[citado 2024 set. 13 ] Available from: https://doi.org/10.1007/s00296-017-3656-y
Vancouver
Rosa Neto NS, Shinjo SK, Levy-Neto M, Pereira R maria R. Vascular surgery: the main risk factor for mortality in 146 Takayasu arteritis patients [Internet]. Rheumatology international. 2017 ; 37( 7): 1065-1073.[citado 2024 set. 13 ] Available from: https://doi.org/10.1007/s00296-017-3656-y

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration